“…To our knowledge, the present research is the first to report the underestimated alteration of association between immunity and the gut microbiome/metabolome, as well as the suppressed SNVs by probiotic consumption in nonpatients. Despite many studies that have been conducted on Lacticaseibacillus rhamnosus Probio-M9 (such as its isolation process, biochemical characteristics [ 60 ], and mouse [ 61 – 63 ], and small-scale human experiments [ 64 ] examining its beneficial effects on hosts), the comprehensive evaluation of Probio-M9 using multiomics data collected from different time points, as presented in this article, greatly compensates for the gaps in probiotic research and significantly increases our understanding of the mechanisms behind the probiotic beneficial effects. However, there are some limitations to this study.…”